Progressive Multiple Cystic Changes in Both Lungs in a Patient Treated with Gefitinib for Lung Adenocarcinoma with Multiple Lung Metastases
Korean Journal of Radiology
;
: 300-304, 2014.
Article
in English
| WPRIM
| ID: wpr-187058
ABSTRACT
Gefitinib is regarded as a relatively safe agent for the treatment of an advanced non-small cell lung cancer (NSCLC). Pulmonary toxicity such as interstitial lung disease associated with gefitinib is uncommon with an estimated all time incidence around 1% worldwide. Moreover, a case of gefitinib associated with pulmonary cystic changes has not been reported yet. In this report we present a case of progressive multiple air cystic changes in both lungs in a patient with NSCLC and intrapulmonary metastases who underwent a gefitinib therapy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Quinazolines
/
Brain Neoplasms
/
Lung Diseases, Interstitial
/
Carcinoma, Non-Small-Cell Lung
/
Cysts
/
Lung
/
Lung Diseases
/
Lung Neoplasms
/
Antineoplastic Agents
Limits:
Female
/
Humans
Language:
English
Journal:
Korean Journal of Radiology
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS